Combined, these results show that although deletion of Ksr2 leads to obesity with increased bone mass, fracture healing is compromised despite the increased bone accretion observed in unfractured bones. The gene discussed is KSR2; the disease is obesity due to melanocortin 4 receptor deficiency.